Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Net Debt Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual net debt in 2023 was 332.43 Million CNY , up 63.82% from previous year.
Austar Lifesciences Limited's latest quarterly net debt in 2024 Q2 was 246.28 Million CNY , down -5.73% from previous quarter.
Austar Lifesciences Limited reported annual net debt of 202.92 Million CNY in 2022, up 569.46% from previous year.
Austar Lifesciences Limited reported annual net debt of -43.22 Million CNY in 2021, up 57.41% from previous year.
Austar Lifesciences Limited reported quarterly net debt of 332.43 Million CNY for 2023 Q4, up 10.33% from previous quarter.
Austar Lifesciences Limited reported quarterly net debt of 332.43 Million CNY for 2023 FY, up 63.82% from previous quarter.

Annual Net Debt Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Net Debt of Austar Lifesciences Limited (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	332.43 Million CNY	63.82%
2022	202.92 Million CNY	569.46%
2021	-43.22 Million CNY	57.41%
2020	-101.48 Million CNY	23.49%
2019	-132.63 Million CNY	22.24%
2018	-170.57 Million CNY	34.92%
2017	-262.11 Million CNY	1.59%
2016	-266.35 Million CNY	25.68%
2015	-358.38 Million CNY	-3.1%
2014	-347.62 Million CNY	-190.38%
2013	-119.71 Million CNY	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	246.28 Million CNY	-5.73%
2023 Q4	332.43 Million CNY	10.33%
2023 FY	332.43 Million CNY	63.82%
2023 Q2	301.3 Million CNY	48.49%
2022 Q4	202.92 Million CNY	142.45%
2022 Q2	83.69 Million CNY	293.63%
2022 FY	202.92 Million CNY	569.46%
2021 FY	-43.22 Million CNY	57.41%
2021 Q2	-234.76 Million CNY	-131.33%
2021 Q4	-43.22 Million CNY	81.59%
2020 Q4	-101.48 Million CNY	-30.05%
2020 FY	-101.48 Million CNY	23.49%
2020 Q2	-78.03 Million CNY	41.17%
2019 Q4	-132.63 Million CNY	-17.78%
2019 FY	-132.63 Million CNY	22.24%
2019 Q2	-112.61 Million CNY	33.98%
2018 Q4	-170.57 Million CNY	24.76%
2018 FY	-170.57 Million CNY	34.92%
2018 Q2	-226.69 Million CNY	13.51%
2017 Q4	-262.11 Million CNY	-23.12%
2017 FY	-262.11 Million CNY	1.59%
2017 Q2	-212.89 Million CNY	20.07%
2016 Q2	-278.13 Million CNY	22.39%
2016 Q4	-266.35 Million CNY	4.24%
2016 FY	-266.35 Million CNY	25.68%
2015 Q4	-358.38 Million CNY	-30.02%
2015 Q2	-275.63 Million CNY	20.71%
2015 FY	-358.38 Million CNY	-3.1%
2014 Q2	-17.34 Million CNY	85.51%
2014 FY	-347.62 Million CNY	-190.38%
2014 Q4	-347.62 Million CNY	-1904.06%
2013 Q4	-119.71 Million CNY	0.0%
2013 FY	-119.71 Million CNY	0.0%

Peer Net Debt Comparison of Austar Lifesciences Limited

Name	Net Debt	Net Debt Difference
Vincent Medical Holdings Limited	-138.39 Million HKD	340.2%